| Publications | PubMed=1568246; DOI=10.1016/0092-8674(92)90407-4
DeClue J.E., Papageorge A.G., Fletcher J.A., Diehl S.R., Ratner N., Vass W.C., Lowy D.R.
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.
Cell 69:265-273(1992) PubMed=7522538; DOI=10.1002/gcc.2870100405
Legius E., Dierick H., Wu R., Hall B.K., Marynen P., Cassiman J.-J., Glover T.W.
TP53 mutations are frequent in malignant NF1 tumors.
Genes Chromosomes Cancer 10:250-255(1994) PubMed=10791998; DOI=10.1172/JCI7610; PMCID=PMC315438
DeClue J.E., Heffelfinger S.C., Benvenuto G., Ling B., Li S.-W., Rui W., Vass W.C., Viskochil D., Ratner N.
Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.
J. Clin. Invest. 105:1233-1241(2000) PubMed=16239399; DOI=10.1124/jpet.105.091454
Mattingly R.R., Kraniak J.M., Dilworth J.T., Mathieu P., Bealmear B., Nowak J.E., Benjamins J.A., Tainsky M.A., Reiners J.J. Jr.
The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines.
J. Pharmacol. Exp. Ther. 316:456-465(2006) PubMed=16510576; DOI=10.1158/0008-5472.CAN-05-3330
Miller S.J., Rangwala F., Williams J., Ackerman P., Kong S., Jegga A.G., Kaiser S., Aronow B.J., Frahm S., Kluwe L., Mautner V.-F., Upadhyaya M., Muir D.F. 4th, Wallace M.R., Hagen J., Quelle D.E., Watson M.A., Perry A., Gutmann D.H., Ratner N.
Large-scale molecular comparison of human Schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.
Cancer Res. 66:2584-2591(2006) PubMed=21481793; DOI=10.1016/j.ccr.2011.02.017; PMCID=PMC3075552
Yi C.-L., Troutman S., Fera D., Stemmer-Rachamimov A.O., Avila J.L., Christian N., Persson N.L., Shimono A., Speicher D.W., Marmorstein R., Holmgren L., Kissil J.L.
A tight junction-associated merlin-angiomotin complex mediates merlin's regulation of mitogenic signaling and tumor suppressive functions.
Cancer Cell 19:527-540(2011) PubMed=28469964; PMCID=PMC5411799
Guo J.-M., Grovola M.R., Xie H., Coggins G.E., Duggan P., Hasan R., Huang J.-L., Lin D.W., Song C., Witek G.M., Berritt S., Schultz D.C., Field J.
Comprehensive pharmacological profiling of neurofibromatosis cell lines.
Am. J. Cancer Res. 7:923-934(2017) PubMed=32076030; DOI=10.1038/s41598-020-59789-4; PMCID=PMC7031337
Amirnasr A., Verdijk R.M., van Kuijk P.F., Kartal P., Vriends A.L.M., French P.J., van Royen M.E., Taal W., Sleijfer S., Wiemer E.A.C.
Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors.
Sci. Rep. 10:2927-2927(2020) PubMed=32642732; DOI=10.1093/noajnl/vdz049; PMCID=PMC7317054
Pemov A., Li H., Presley W., Wallace M.R., Miller D.T.
Genetics of human malignant peripheral nerve sheath tumors.
Neurooncol. Adv. 2:i50-i61(2020) |
|---|
